Matches in Nanopublications for { ?s ?p "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP1092044.RAT5RQsvLNOFsm4hCCqGhwzXXpkq9xsot-fRNgreO7OoU130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092044.RAT5RQsvLNOFsm4hCCqGhwzXXpkq9xsot-fRNgreO7OoU130_provenance.
- NP1092051.RAaodq3s4d6zswLdMVoaRlo5NnY7lAZqZ184uZ8sqyVmo130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092051.RAaodq3s4d6zswLdMVoaRlo5NnY7lAZqZ184uZ8sqyVmo130_provenance.
- NP1092053.RAfI4mVYtRBYA5Sy-sLQXPblgjoQc87mrjx5giGYWVczg130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092053.RAfI4mVYtRBYA5Sy-sLQXPblgjoQc87mrjx5giGYWVczg130_provenance.
- NP1092041.RACVpo11Nytr6koSvae3HhxRp49piCtBDqXbIfXQ_3G9A130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092041.RACVpo11Nytr6koSvae3HhxRp49piCtBDqXbIfXQ_3G9A130_provenance.
- NP1092046.RAtTmQDV_gkXYsCrmnvFtn7nJ2IJq3sVOo2nX0g_Dwvyg130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092046.RAtTmQDV_gkXYsCrmnvFtn7nJ2IJq3sVOo2nX0g_Dwvyg130_provenance.
- NP1092050.RAhyZOAHELFnaGBMRN6nCIKf3_eAXF2NLYzbxzbj88KD4130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092050.RAhyZOAHELFnaGBMRN6nCIKf3_eAXF2NLYzbxzbj88KD4130_provenance.
- NP1092040.RAFfl0ZE69loQaYr-w9wMje1Mkt-yChtWvfvF8aN_sW9I130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092040.RAFfl0ZE69loQaYr-w9wMje1Mkt-yChtWvfvF8aN_sW9I130_provenance.
- NP1092047.RAI1iqwMnjXagNB4TmrdGstaJjxj18E9-r787NOPcOGAc130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092047.RAI1iqwMnjXagNB4TmrdGstaJjxj18E9-r787NOPcOGAc130_provenance.
- NP1092055.RAMM_159DwyyEf3R7tz6S2OsKIMvc6SbRnXMOhaiPSRfw130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092055.RAMM_159DwyyEf3R7tz6S2OsKIMvc6SbRnXMOhaiPSRfw130_provenance.
- NP1092057.RALnKcyVBWcOkgnzZwbxToMqLnBI5kWl5ycOVtv8WkfiY130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092057.RALnKcyVBWcOkgnzZwbxToMqLnBI5kWl5ycOVtv8WkfiY130_provenance.
- NP1092049.RA_aZNNrlIzExF1mkECdO3PWnzkt1EE1k6LdzdphNTQ8Y130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092049.RA_aZNNrlIzExF1mkECdO3PWnzkt1EE1k6LdzdphNTQ8Y130_provenance.
- NP1092054.RAwIQoFFwjpF1JEH2DhY846sS4QAlrL1TEIenbaTfVYJ4130_assertion description "[Mutations were present in 18 of 80 PTCs (22.5%), in 40 of 78 (51%) advanced thyroid cancers (ATC + PDTC) (P = 3 � 10(-4) vs PTC), and in widely invasive HCCs (4 of 17), but not in minimally invasive HCCs (0 of 8).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092054.RAwIQoFFwjpF1JEH2DhY846sS4QAlrL1TEIenbaTfVYJ4130_provenance.